bioAffinity Technologies, Inc. (BIAF)
NASDAQ: BIAF · Real-Time Price · USD
1.820
-0.030 (-1.62%)
At close: Sep 18, 2024, 4:00 PM
1.930
+0.110 (6.04%)
After-hours: Sep 18, 2024, 5:45 PM EDT
bioAffinity Technologies Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Revenue | 7.32 | 2.53 | 0 | - | - |
| Revenue Growth (YoY) | 30185.99% | 52627.44% | - | - | - |
| Cost of Revenue | 4.72 | 1.74 | 0 | - | - |
| Gross Profit | 2.6 | 0.79 | 0 | - | - |
| Selling, General & Admin | 8.9 | 6.79 | 2.48 | 1.07 | 0.99 |
| Research & Development | 1.86 | 1.72 | 1.52 | 1.14 | 1.61 |
| Operating Expenses | 11.27 | 8.76 | 4.02 | 2.21 | 2.6 |
| Operating Income | -8.67 | -7.97 | -4.01 | -2.21 | -2.6 |
| Interest Expense | -0.08 | -0.04 | -2.53 | -1 | -0.38 |
| Interest & Investment Income | 0.05 | 0.12 | 0.05 | 0 | 0 |
| Other Non Operating Income (Expenses) | -0.02 | -0.03 | -1.87 | -3.36 | -4.28 |
| EBT Excluding Unusual Items | -8.72 | -7.92 | -8.36 | -6.56 | -7.27 |
| Other Unusual Items | - | - | 0.21 | 0.24 | - |
| Pretax Income | -8.72 | -7.92 | -8.15 | -6.32 | -7.27 |
| Income Tax Expense | 0.01 | 0.02 | 0 | 0 | 0 |
| Net Income | -8.74 | -7.94 | -8.15 | -6.33 | -7.27 |
| Net Income to Common | -8.74 | -7.94 | -8.15 | -6.33 | -7.27 |
| Shares Outstanding (Basic) | 10 | 9 | 4 | 3 | 3 |
| Shares Outstanding (Diluted) | 10 | 9 | 4 | 3 | 3 |
| Shares Change (YoY) | 33.03% | 94.43% | 68.17% | 0.02% | - |
| EPS (Basic) | -0.89 | -0.91 | -1.81 | -2.36 | -2.72 |
| EPS (Diluted) | -0.89 | -0.91 | -1.81 | -2.36 | -2.72 |
| Free Cash Flow | -7.08 | -6.06 | -4.29 | -2.05 | -2.21 |
| Free Cash Flow Per Share | -0.72 | -0.69 | -0.95 | -0.77 | -0.83 |
| Gross Margin | 35.47% | 31.26% | 90.28% | - | - |
| Operating Margin | -118.51% | -314.84% | -83511.51% | - | - |
| Profit Margin | -119.41% | -313.41% | -169771.25% | - | - |
| Free Cash Flow Margin | -96.83% | -239.32% | -89336.50% | - | - |
| EBITDA | -8.03 | -7.6 | -4 | -2.2 | -2.58 |
| EBITDA Margin | -109.82% | -299.91% | - | - | - |
| D&A For EBITDA | 0.64 | 0.38 | 0.01 | 0 | 0.02 |
| EBIT | -8.67 | -7.97 | -4.01 | -2.21 | -2.6 |
| Advertising Expenses | - | 0.09 | 0.04 | - | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.